To include your compound in the COVID-19 Resource Center, submit it here.

Management tracks: TapImmune, Camel-IDS, Arvinas

Immuno-oncology company TapImmune Inc. (NASDAQ:TPIV) named Peter Hoang president and CEO. He was SVP of business development and strategy at Bellicum Pharmaceuticals Inc. (NASDAQ:BLCM).

Cancer company

Read the full 254 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE